Literature DB >> 16160919

Mutational analysis of human BAFF receptor TNFRSF13C (BAFF-R) in patients with common variable immunodeficiency.

Claretta Gioia Losi1, Antonietta Silini, Claudia Fiorini, Annarosa Soresina, Antonella Meini, Simona Ferrari, Luigi D Notarangelo, Vassilios Lougaris, Alessandro Plebani.   

Abstract

BAFF receptor (BAFF-R/BR3/TNFRSF13C) is a recently identified molecule that specifically binds BLyS, a protein belonging to the tumor necrosis factor (TNF) family, and is involved in survival and maturation of B cells. Recent studies have demonstrated that mice defective in BAFF-R gene exhibit an altered profile of the B cell pool, a phenotype observed in BLyS knockout mice as well. These features suggest that mutations in this gene may result in humoral immunodeficiency. To test this hypothesis, we sequenced the BAFF-R gene in 48 patients with common variable immunodeficiency (CVID) along with 57 healthy controls. We have identified three novel variants present at the heterozygous state leading to amino acid substitutions, and have also confirmed the existence of a previously reported intronic variant. The hereby described novel variants were also present in healthy controls and in the healthy patients' parents. These variants do not affect the expression of BAFF-R neither at the mRNA nor at the protein level, suggesting that these variants represent novel polymorphic variants of the BAFF-R gene.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16160919     DOI: 10.1007/s10875-005-5637-2

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  13 in total

Review 1.  The molecular architecture of the TNF superfamily.

Authors:  Jean-Luc Bodmer; Pascal Schneider; Jürg Tschopp
Journal:  Trends Biochem Sci       Date:  2002-01       Impact factor: 13.807

2.  BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF.

Authors:  J S Thompson; S A Bixler; F Qian; K Vora; M L Scott; T G Cachero; C Hession; P Schneider; I D Sizing; C Mullen; K Strauch; M Zafari; C D Benjamin; J Tschopp; J L Browning; C Ambrose
Journal:  Science       Date:  2001-08-16       Impact factor: 47.728

3.  Absence of memory B cells in patients with common variable immunodeficiency.

Authors:  Kazunaga Agematsu; Takeshi Futatani; Sho Hokibara; Norimoto Kobayashi; Masaya Takamoto; Satoshi Tsukada; Harumi Suzuki; Shigeo Koyasu; Toshio Miyawaki; Kazuo Sugane; Atsushi Komiyama; Hans D Ochs
Journal:  Clin Immunol       Date:  2002-04       Impact factor: 3.969

4.  An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway.

Authors:  B Schiemann; J L Gommerman; K Vora; T G Cachero; S Shulga-Morskaya; M Dobles; E Frew; M L Scott
Journal:  Science       Date:  2001-08-16       Impact factor: 47.728

5.  Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency.

Authors:  Bodo Grimbacher; Andreas Hutloff; Michael Schlesier; Erik Glocker; Klaus Warnatz; Ruth Dräger; Hermann Eibel; Beate Fischer; Alejandro A Schäffer; Hans W Mages; Richard A Kroczek; Hans H Peter
Journal:  Nat Immunol       Date:  2003-02-10       Impact factor: 25.606

6.  B cell-activating factor belonging to the TNF family (BAFF)-R is the principal BAFF receptor facilitating BAFF costimulation of circulating T and B cells.

Authors:  Lai Guan Ng; Andrew P R Sutherland; Rebecca Newton; Fang Qian; Teresa G Cachero; Martin L Scott; Jeffrey S Thompson; Julie Wheway; Tatyana Chtanova; Joanna Groom; Ian J Sutton; Cynthia Xin; Stuart G Tangye; Susan L Kalled; Fabienne Mackay; Charles R Mackay
Journal:  J Immunol       Date:  2004-07-15       Impact factor: 5.422

7.  TNF family member B cell-activating factor (BAFF) receptor-dependent and -independent roles for BAFF in B cell physiology.

Authors:  Yoshiteru Sasaki; Stefano Casola; Jeffery L Kutok; Klaus Rajewsky; Marc Schmidt-Supprian
Journal:  J Immunol       Date:  2004-08-15       Impact factor: 5.422

8.  Cutting edge: BAFF regulates CD21/35 and CD23 expression independent of its B cell survival function.

Authors:  Leonid Gorelik; Anne H Cutler; Greg Thill; Steven D Miklasz; Dianna E Shea; Christine Ambrose; Sarah A Bixler; Lihe Su; Martin L Scott; Susan L Kalled
Journal:  J Immunol       Date:  2004-01-15       Impact factor: 5.422

9.  B cell-activating factor belonging to the TNF family acts through separate receptors to support B cell survival and T cell-independent antibody formation.

Authors:  Svetlana Shulga-Morskaya; Max Dobles; Meghan E Walsh; Lai Guan Ng; Fabienne MacKay; Sambasiva P Rao; Susan L Kalled; Martin L Scott
Journal:  J Immunol       Date:  2004-08-15       Impact factor: 5.422

10.  Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations.

Authors:  F Mackay; S A Woodcock; P Lawton; C Ambrose; M Baetscher; P Schneider; J Tschopp; J L Browning
Journal:  J Exp Med       Date:  1999-12-06       Impact factor: 14.307

View more
  34 in total

1.  Monoallelic BAFFR P21R/H159Y Mutations and Familiar Primary Antibody Deficiencies.

Authors:  Vassilios Lougaris; Manuela Baronio; Daniele Moratto; Fabio Cardinale; Alessandro Plebani
Journal:  J Clin Immunol       Date:  2015-11-27       Impact factor: 8.317

2.  Thymic and bone marrow output in patients with common variable immunodeficiency.

Authors:  Federico Serana; Paolo Airò; Marco Chiarini; Cinzia Zanotti; Mirko Scarsi; Micol Frassi; Vassilios Lougaris; Alessandro Plebani; Luigi Caimi; Luisa Imberti
Journal:  J Clin Immunol       Date:  2011-04-14       Impact factor: 8.317

Review 3.  Common variable immune deficiency: Dissection of the variable.

Authors:  Charlotte Cunningham-Rundles
Journal:  Immunol Rev       Date:  2019-01       Impact factor: 12.988

Review 4.  Human B cell defects in perspective.

Authors:  Charlotte Cunningham-Rundles
Journal:  Immunol Res       Date:  2012-12       Impact factor: 2.829

5.  Mutation in IRF2BP2 is responsible for a familial form of common variable immunodeficiency disorder.

Authors:  Michael D Keller; Rahul Pandey; Dong Li; Joseph Glessner; Lifeng Tian; Sarah E Henrickson; Ivan K Chinn; Linda Monaco-Shawver; Jennifer Heimall; Cuiping Hou; Frederick G Otieno; Soma Jyonouchi; Leonard Calabrese; Joris van Montfrans; Jordan S Orange; Hakon Hakonarson
Journal:  J Allergy Clin Immunol       Date:  2016-03-23       Impact factor: 10.793

Review 6.  Tolerance and autoimmunity in primary immunodeficiency disease: a comprehensive review.

Authors:  Sudhir Gupta; Ankmalika Gupta Louis
Journal:  Clin Rev Allergy Immunol       Date:  2013-10       Impact factor: 8.667

Review 7.  Primary B-cell immunodeficiencies.

Authors:  Tukisa Smith; Charlotte Cunningham-Rundles
Journal:  Hum Immunol       Date:  2018-10-22       Impact factor: 2.850

8.  Reduced BAFF-R and increased TACI expression in common variable immunodeficiency.

Authors:  Rita R Barbosa; Susana L Silva; Sara P Silva; Alcinda C Melo; M Conceição Pereira-Santos; João T Barata; Lennart Hammarström; Marília Cascalho; Ana E Sousa
Journal:  J Clin Immunol       Date:  2014-05-09       Impact factor: 8.317

9.  A BAFF-R mutation associated with non-Hodgkin lymphoma alters TRAF recruitment and reveals new insights into BAFF-R signaling.

Authors:  Joanne M Hildebrand; Zhenghua Luo; Michelle K Manske; Tammy Price-Troska; Steven C Ziesmer; Wai Lin; Bruce S Hostager; Susan L Slager; Thomas E Witzig; Stephen M Ansell; James R Cerhan; Gail A Bishop; Anne J Novak
Journal:  J Exp Med       Date:  2010-11-01       Impact factor: 14.307

Review 10.  Common variable immunodeficiency: etiological and treatment issues.

Authors:  Sean Deane; Carlo Selmi; Stanley M Naguwa; Suzanne S Teuber; M Eric Gershwin
Journal:  Int Arch Allergy Immunol       Date:  2009-07-01       Impact factor: 2.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.